FDA Clearance
FDA grants accelerated approval to Iovance’s melanoma cell therapy
February 21, 2024
T2 Biosystems gets FDA nod to expand bacteria panel
February 12, 2024
Why many high-risk IVDs are being reclassified
February 1, 2024
Page 1 of 7
Next Page